September 15, 2013 / 6:50 AM / 4 years ago

Sun Pharma gets U.S. FDA nod for Prevacid generic drug

A worker stocks shelves at a temporary CVS store in the Rockaway Beach neighborhood of Queens, New York, November 13, 2012.Brendan McDermid/Files

MUMBAI (Reuters) - Sun Pharmaceutical Industries Ltd (SUN.NS) said its unit has received U.S. Food and Drug Administration's (USFDA) final approval for the generic version of Prevacid.

The approval is for Lansoprazole Delayed-Release Capsules USP, 15 and 30 mg, which are therapeutic equivalents of Takeda Pharmaceutical Co. Ltd's capsules, the company said in a release late on Saturday.

The capsules have annual sales of $430 million in the United Sates, it said.

The capsules are used for short-term treatment for healing and symptom relief of active duodenal ulcer, it said.

Reporting by Subhadip Sircar; Editing by Robert Birsel

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below